Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (191-200 of 525) with videos related to

Pageof 53
Sort By:
Oncotarget|June 8, 2011
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATPYulan Cheng, Jian Yang, Rachana Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerYing Chen, Mrudula Pullambhatla, Catherine A Foss, et al.
Clinical Nuclear Medicine|August 15, 2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CTSteven P Rowe, Michael A Gorin, Linda C Chu, et al.
Journal of Neurotrauma|September 20, 2017
Changes in [<sup>18</sup>F]Fluorodeoxyglucose Activities in a Shockwave-Induced Traumatic Brain Injury Model Using LithotripsyAfshin A Divani, Jenny-Ann Phan, Pascal Salazar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
PET Imaging of Accessible Prostate-Specific Membrane Antigen Reveals Dose-Dependent and Tumor Burden-Driven VariabilityAkhilesh Mishra, Ala Lisok, Ronnie C Mease, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Magnetic Resonance Imaging|August 7, 2010
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy studyMona A Mohamed, Peter B Barker, Richard L Skolasky, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2017
Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunitsGenevieve E Lind, Tung-Chung Mou, Lucia Tamborini, et al.
Molecular Cancer Therapeutics|July 9, 2009
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenograftsBachchu Lal, C Rory Goodwin, Yingying Sang, et al.
Radiology|January 23, 2010
Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementiaMona A Mohamed, Margaret R Lentz, Vallent Lee, et al.
Pageof 53

Showing results (191-200 of 525) with videos related to

Sort By:
Pageof 53
Oncotarget|June 8, 2011
Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATPYulan Cheng, Jian Yang, Rachana Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerYing Chen, Mrudula Pullambhatla, Catherine A Foss, et al.
Clinical Nuclear Medicine|August 15, 2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CTSteven P Rowe, Michael A Gorin, Linda C Chu, et al.
Journal of Neurotrauma|September 20, 2017
Changes in [<sup>18</sup>F]Fluorodeoxyglucose Activities in a Shockwave-Induced Traumatic Brain Injury Model Using LithotripsyAfshin A Divani, Jenny-Ann Phan, Pascal Salazar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
PET Imaging of Accessible Prostate-Specific Membrane Antigen Reveals Dose-Dependent and Tumor Burden-Driven VariabilityAkhilesh Mishra, Ala Lisok, Ronnie C Mease, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Magnetic Resonance Imaging|August 7, 2010
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy studyMona A Mohamed, Peter B Barker, Richard L Skolasky, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2017
Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunitsGenevieve E Lind, Tung-Chung Mou, Lucia Tamborini, et al.
Molecular Cancer Therapeutics|July 9, 2009
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenograftsBachchu Lal, C Rory Goodwin, Yingying Sang, et al.
Radiology|January 23, 2010
Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementiaMona A Mohamed, Margaret R Lentz, Vallent Lee, et al.
Pageof 53